Antibiotic reduction strategy found safe for severe sepsis
NCT ID NCT01626612
First seen May 12, 2026 · Last updated Jun 12, 2026 · Updated 10 times
Summary
This study looked at whether doctors can safely reduce or narrow the antibiotics given to patients with severe sepsis once the exact germ causing the infection is identified. The goal was to see if this approach, called de-escalation, is as good as continuing the original broad antibiotics. The trial involved 120 adults in intensive care units and measured how long they stayed in the ICU, death rates, and the rise of drug-resistant germs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
Conditions
Explore the condition pages connected to this study.